Syntal Capital Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Syntal Capital Partners, LLC

  • $10 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 26, 2020
SELL
$544.75 - $658.21 $1.1 Million - $1.33 Million
-2,015 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $994,039 - $1.3 Million
2,015 New
2,015 $1.26 Million
Q3 2019

Nov 14, 2019
SELL
$273.46 - $318.39 $273,460 - $318,390
-1,000 Closed
0 $0
Q4 2017

Jan 18, 2018
BUY
$358.63 - $469.95 $358,630 - $469,950
1,000
1,000 $375,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Syntal Capital Partners, LLC Portfolio

Follow Syntal Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syntal Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email